UAB was among the first medical centers in the country to obtain a MEG, having done so originally in 2001; however, evolving technology has created a need for replacing the old technology with a new one.

Leveraging the existing Alabama Trauma and Statewide Stroke systems, UAB and ADPH have created a model for a more integrated and effective system of emergency stroke care.

Results suggest that, rather than stimulating both sides of the brain using DBS, unilateral right DBS may avoid DBS-related declines in verbal fluency and response inhibition in patients with movement disorders like Parkinson’s disease.

UAB Medicine has received the American Heart Association’s Get With The Guidelines® - Stroke Gold Plus with the added distinctions of Target: Stroke℠ Honor Roll Elite Plus and Target: Type 2 Diabetes™ Honor Roll.

For 11 consecutive years, U.S. News has named UAB Hospital the best hospital in Alabama, with several specialties and procedures ranked among the best.

The Goldwater Program received 1,353 nominations from 446 institutions this year, and the winners will receive a scholarship covering tuition, housing, fees and books.

The annual race will be held Saturday, May 18, at Railroad Park. A virtual option will be offered this year.

These findings could lead to non-invasive, low-cost tests and the early diagnosis of the disease, which progresses for decades before symptoms of dementia emerge.   

While preventive treatment with vigabatrin delayed the onset and prevalence of infantile spasms in TSC infants, it had no impact on focal seizures, drug-resistant epilepsy, or improvement of cognitive and behavioral scores at 24 months.

In a mouse model, border-associated macrophages, not microglia, were essential for the neuroinflammation that precedes neurodegradation. Targeting this subset could be a disease-modifying therapy in neurodegenerative disease.

The study, utilizing the relatively new field of metagenomics, demonstrated an imbalance in the gut microbiome of patients with Parkinson’s disease.

Radiofrequency ablation precisely delivers heat energy that can destroy lesions within the brain that are the cause of seizures.

The fields of neuroengineering and brain-computer interfaces could have a tremendous impact on a number of neurologic conditions, such as stroke, neurodegenerative disorders, Parkinson’s disease, dementia and other brain diseases.

Consortium led by UAB researchers in the UAB Heersink School of Medicine and School of Public Health received additional funding to further study chronic hypertension and preeclampsia epigenetics participants enrolled in the CHAP trial.

Limiting neuroinflammation may represent a promising new approach to treat neurological diseases driven by neuroinflammation, such as stroke, spinal cord injury and neuropathic pain.

A new multidisciplinary program within UAB Medicine will help evaluate patients who have recovered from COVID-19 but are still experiencing symptoms and link them to the specialized care they need.

A grant to the UAB stroke center will help maximize a state health department effort to better manage strokes in Alabama.

Study points to a potential immediate treatment for this devastating disease.

UAB neurologists have reported the first case study of a patient with a brain bleed linked to consumption of an energy drink.

A multisite study led by UAB has found the first biomarker for the onset of seizures in infants with tuberous sclerosis.